4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-036427
Chief Commercial Officer sold 543 shares at $2.67 ($1,450)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Marshak Richard Chief Commercial Officer | 2026-05-15 | Sale | −543 | $2.67 | $1,450 | 125,101 | D |
| Open-market sales · 543 sh · avg $2.67 · $1,450 | |||||||
Loading xslF345X06/wk-form4_1779221287.xml…